knowledge -WSS

knowledge

author：fashion 2025-08-08 10:29:30 - browse：613

UnitedHealth CEO Andrew Witty testifies before the Senate Finance Committee on Capitol Hill on May 1, 2024 in Washington — Kent Nishimura/Getty Images

Change Healthcare can notify patients whose sensitive health information has been exposed as a result of the massive security breach at the health care payments clearinghouse in February, the Department of Health and Human Services said Friday.

This long-awaited update from the federal agency answers questions from hospitals and doctors around the country, who were worried they would have to track down the roughly 30% of Americans whose data may have been stolen. Federal law requires health care providers to inform patients when their data has been exposed.

Just last week, over 100 provider industry groups sent a letter to HHS secretary Xavier Becerra asking the agency’s Office of Civil Rights, which handles HIPAA data breaches, to clarify that Change Healthcare and its parent company UnitedHealth Group are responsible for finding and notifying affected customers, not individual hospitals, doctors’ offices, and other health care providers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Can U.S. cancer drug shortages be fixed?

WSS

PBMs are inflating the cost of generic drugs. They must be reined in

Vivek Ramaswamy made waves in the debate, much as in biotech

FDA advisory panel to debate high blood pressure devices

FDA greenlights medical device to combat bladder issues

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

knowledge

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Trans patients at the end of life deserve respect and dignity

Peter Hotez and the public health issue of online harassment

California store owner shot dead in dispute over displaying Pride flag: Police

Drug repurposing or repositioning? The language matters

Trans patients at the end of life deserve respect and dignity

Novavax promises a turnaround & Lilly roils the obesity market

Former Pear Therapeutics executives start new VC firm

The high cost of giving birth even with insurance

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

focus

Former Pear Therapeutics executives start new VC firm

PBMs are inflating the cost of generic drugs. They must be reined in

FDA greenlights medical device to combat bladder issues

Intellia plays down concerns on accidental germline transmission

Vivek Ramaswamy made waves in the debate, much as in biotech

PBMs are inflating the cost of generic drugs. They must be reined in

explore

hotspot

entertainment

leisure time